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ABSTRACT
Impact microindentation (IMI) is a new technique for the in vivo measurement of tissue-level properties of cortical bone in humans.
To address issues related to the proper application of IMI in clinical practice and to directly examine cortical bone properties in
patients with tibia pathology, we studied 11 subjects without tibia pathology and nine patients with Paget’s disease of the tibia in
biochemical remission after bisphosphonate treatment. Serial indentations in the tibias of both legs were performed in all subjects
by a single operator until 10 adequate measurements were obtained in each tibia. In patients without Paget’s disease (7 men and
4women;mean age, 61.9 years; range, 51 to 72 years), there was no difference inmean bonematerial strength index (BMSi) between
the dominant and nondominant leg (82.1 1.3 and 81.4 1.3, respectively; p¼ 0.606). In each individual subject studied, sequential
indentations in both legs showed no trends for higher or lower values with time. The standard deviation of unnormalized bone
material strength (BMSu)was also comparable between the dominant and nondominant tibia (5.3 and 4.5, respectively; p¼ 0.657). In
patients with Paget’s disease (4 men and 5 women; mean age, 69.5 years; range, 55 to 87 years), mean BMSi of the Pagetic tibia was
lower, albeit nonsignificantly, than that of the contralateral nonaffected tibia (74.7 1.7 and 78.7 1.3, respectively; p¼ 0.120). In
contrast to subjectswithout Paget’s disease, the SD of adequate BMSu valueswas significantly larger in the Pagetic tibia compared to
that of the non-Pagetic tibia (7.6 versus 5.0, respectively, p¼ 0.008). These results highlight the consistency of serial IMI
measurements as performed by a single operator in the presence aswell as absence of tibia pathology and illustrate that themethod
is able to capture alterations of tissue-level cortical bone properties in patients with Paget’s disease of the tibia. © 2017 The Authors.
Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
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Introduction
Impact microindentation (IMI) is a new reference pointindentation technique that measures tissue-level properties
of cortical bone in humans in vivo at the mid-shaft of the tibia.
The tool used to perform IMI is a hand-held device (OsteoProbe;
Active Life Scientific, Santa Barbara, CA, USA) that imparts a
single impact load to the bone surface. The methodology and
clinical value of the method have been recently reviewed.(1–3) In
the course of the investigation, repeated indentations are
performed on the tibia until a minimum number of adequate
measurements is obtained. Themanufacturer of the device does
not provide an algorithm to automatically flag inadequate
measurements, the evaluation of which is left to the judgment of
the operator during the procedure. To our knowledge, the
variance of measurements obtained in an individual subject by
sequential adequate indentations has not been previously
reported. Moreover, whereas the nondominant leg is
recommended as the preferred investigation site,(3) data
supporting this recommendation are not available. An impor-
tant, clinically relevant question is whether the application of IMI
is informative and reliable in patients with tibia pathology,
particularly as pathology at this site has so far been considered
as an exclusion criterion. IMI measurements may indeed provide
valuable information not only on the tissue-level properties of
the diseased tibia, but also on the performance of the technique
in general.
To address these questions and to obtain more insight into
the value of IMI in clinical practice, we examined tissue-level
properties of cortical bone of both legs in individuals without
tibia pathology and in patients with Paget’s disease of the tibia.
Localizations of Pagetic lesions in the tibia can be found in the
original description of the disease by Sir James Paget in 1887,(4)
and we have previously reported that lesions of the tibia
comprised 7% of all Pagetic lesions in 180 consecutive patients
from our cohort of patients with Paget’s disease of bone.(5)
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Paget’s disease of the tibia has characteristic radiologic features
such as cortical thickening and abnormal bone texture (Fig. 1)
and may be associated with significant deformity, pain, and
increased risk of stress and complete fractures.(6)
Patients and Methods
IMI was performed in all subjects by a single operator (FM) in the
Out-Patient Clinic of the Center for Bone Quality of the Leiden
UniversityMedical Center (LUMC). The group of patients without
tibia pathology included in this study consisted of consecutive
patients attending our Out-Patient Clinic who participated in our
studies of tissue-level properties of cortical bone in patients with
and without fractures and with well-controlled acromegaly and
who consented to having further IMI measurements undertaken
in both legs. Details of the characteristics and selection of these
patients have been published.(7,8) Exclusion criteria included
localized infection of the tibia, metabolic bone disease other
than osteoporosis, any untreated endocrine disorder, bilateral
hip replacement, severe liver insufficiency, chronic kidney
disease stage IV or V, and current or past use of glucocorticoids
with the exception of hydrocortisone supplementation for
secondary adrenal insufficiency in patients with acromegaly and
inability to provide informed consent. All patients with
radiologically confirmed Paget’s disease of the tibia who were
followed regularly in our Center and were in remission after
treatment with bisphosphonates were also studied. The study
was approved by theMedical Ethics Committee of the LUMC and
all participants provided written informed consent.
Data on age, gender, height and weight, history of fractures,
and use of medications (current and previous) were docu-
mented in all patients included in the study. In subjects without
Paget’s disease, the presence of morphometric vertebral
fractures was examined by spine radiographs and bone mineral
density was measured by DXA. In patients with Paget’s disease
the date of diagnosis of the disease and dates, type, and number
of bisphosphonate treatments were recorded and radiographs
of the tibias were reviewed to confirm the presence of a Pagetic
lesion of the tibia.
Laboratory investigations
Blood was collected and serum measured for calcium,
phosphate, albumin, and creatinine using semiautomated
techniques, for alkaline phosphatase (ALP) using a fully-
automated P800 modulator system (Roche Diagnostics), for
procollagen type 1 amino-terminal propeptide (P1NP) using an
electrochemiluminescent immunoassay with a Modular Analyt-
ics E-170 system (Roche Diagnostics) and for 25-hydroxyvitamin
D using the 25-OH-vitamin D TOTAL assay (DiaSorin D.A./N.V.).
Plasma was measured for intact PTH using the Immulite 2500
assay (Siemens Diagnostics).
IMI
Bonematerial strength index (BMSi) wasmeasured in all subjects
by IMI applied to the mid-shaft of the tibia by a single operator
(FM) using a hand-held microindenter (OsteoProbe RUO; Active
Life Scientific), as previously described and recommended by a
group of experts.(3) The patient was placed in a decubitus supine
position with the tibia in external rotation to orient the flat
surface of the medial tibia diaphysis in a horizontal position.
Indentations of both tibias were performed in a single session
without repositioning of the patient. The measurement site was
defined as the midpoint of the distance between the distal apex
of the patella and medial malleolus. The operator ensured that
the test probe was placed perpendicularly to the bone surface
and classified the measurements as “well performed,” “ade-
quate,” or “poorly performed” after the indentation and before
checking the computer display according to the following
criteria: “well performed”when the operator judged that the test
probe was exactly perpendicular to the bone surface; “ade-
quate” when the test probe was within acceptable deviation
from the bone surface(9); “poorly performed”when the operator
judged that the test probe was not appropriately placed. “Poorly
performed”measurements are usually due to slipping of the test
probe, moving of the subject’s leg or failure to place the device
perpendicularly to the bone surface and are excluded from
the analysis. In the present study the operator continued the
protocol until 10 adequate measurements were obtained. Five
additional measurements were subsequently performed on a
calibration phantom, a cube of polymethylmethacrylate
(PMMA), firmly secured in a holder and placed on a stable
surface. BMSi is calculated as 100 times the harmonic mean of
the indentation distance increase from impact into the PMMA
material divided by the indentation distance increase from
impact into the bone.(3) Another parameter, unnormalized bone
material strength (BMSu), has been used in the original
description of the method to describe the effects of instrument
variables on measurements.(9) We concluded that BMSu directly
obtained by measurement of individual sequential indentations
is more suitable for the analysis of variability of the procedure
than BMSi, which is the final result of all sequential measure-
ments in a single patient after correction with the PMMA
calibration phantom. Normalization of the measured values to
the calibration phantom, as done in the standard calculation of
Fig. 1. Characteristic radiographic features of the tibias of two patients
with Paget’s disease of bone included in the study.
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BMSi, would remain relatively consistent when a variable, such
as probe sharpness or indentation angle, is changed. BMSu is
defined as 100 times the ratio of the ideal indentation distance
increase from the impact into PMMA (150 mm) divided by the
indentation distance increase from the impact into the bone
sample. We used this parameter for the calculation of variability
of sequential measurements in the same subject and we
arbitrarily defined it BMSu as opposed to BMSi.
The intraobserver coefficient of variation (CV) of the technique
was calculated to be 2.2% in a previous study of patients with low
bone mass with or without fractures by measuring BMSi twice in
the right leg according to the abovementioned protocol with the
second investigation performed 2 cm below the first measure-
ment site in 10 subjects.(10) Mean SD BMSi of the two
measurements was 75.9 5.7 and 76.6 4.9, respectively.
Statistical analysis
Indentations judged “poorly performed” by the operator were
not included in the calculation of the final BMSi or in the
variation analyses. Results are reported as mean SE unless
otherwise stated. Between-group differences in baseline
characteristics were assessed using a Student’s t test, a chi-
square test, or a Mann-Whitney U test for non-normally
distributed variables. Pearson’s and Spearman’s correlations
were used to assess correlations between BMSi and patients’
parameters that were normally and not normally distributed. A
paired t test was used to compare BMSi values between both
tibias. A Wilcoxon signed ranks test was used to compare the
standard deviation of the 10 adequate BMSu values between
both tibias. Differences were considered to be significant at
p< 0.05. All analyses were performed using SPSS software for
Windows (version 23.0; IBMCorp, Armonk, NY, USA). Scatterplots
were constructed with Graphpad Prism (version 7.0; Graphpad
Software Inc., La Jolla, CA, USA); BMSu values were plotted in the
sequence they were obtained from the first to the last.
Results
We studied 11 consecutively presenting individuals (7 men)
aged 61.9 years (range, 51 to 72 years) and BMI 27.3 1.7,
without pathology of the lower extremities and who consented
to bilateral IMI measurements. Four had osteoporosis, five had
osteopenia, and two had normal bone mineral density. Two
patients with osteoporosis had a history of a clinical vertebral
fracture and one with osteopenia of a distal radius fracture. Five
patients from the acromegaly cohort had morphometric
vertebral fractures. In all subjects studied biochemical param-
eters of bone and mineral metabolism were within the normal
laboratory reference ranges (not shown). Nine patients (4 men)
with Paget’s disease of the tibia with a mean age of 69.5 years
(range, 55 to 87 years), and BMI 27.5 1.1, who were in
biochemical remission for at least 1 year after treatment with
bisphosphonates (median, 5.5 years; range, 1 to 30 years) were
also studied. At the time of the investigation mean serum
alkaline phosphatase activity was 76.7 5.7 IU/L (reference
range, 40 to 120 IU/L) and serum P1NP was 41.8 4.6 ng/mL
(reference range <65 ng/mL).
IMI in subjects without tibia pathology
In subjects without Paget’s disease a mean of 12 indentations
(range, 11 to 15) were performed in the dominant leg and 12
indentations (range, 10 to 14) in the nondominant leg in order to
obtain 10 adequate measurements in each tibia of all tested
individuals. Inadequate measurements were evenly spread
during the procedure with the exception of the first indentation
that was classified as “poorly performed” by the operator in 10 of
the 22 measurements (7/14 and 3/8 measurements in
acromegaly and remaining patients, respectively). Mean BMSi
of the dominant leg was not different from that of the
nondominant leg (82.1 1.3 and 81.4 1.3, respectively;
p¼ 0.606). Individual adequate measurements of the same tibia
generally showed minimal variations (Fig. 2A), but larger
variations were also observed (Fig. 2B), which did not in any
case affect the mean BMSi value. These larger variations were
not operator-dependent and bore no relation to the sequence
timing of the indentation. This is illustrated in Fig. 3 by the lack of
a trend toward lower or higher values or alterations in the
magnitude of SDs of the mean BMSu of sequential adequate
indentations. Mean SDs of BMSu of the dominant and
nondominant legs were overall not different (5.3 and 4.5,
respectively; p¼ 0.657). Similarly, there was no difference in
mean SD of BMSu of the right and left leg (5.1 and 4.7,
respectively; p¼ 0.657). There was no difference in BMSi values
after five or 10 adequate measurements in either investigated
leg (82.7 1.2 versus 82.1 1.3 and 81.1 1.3 versus 81.4 1.3
for the dominant and nondominant leg, respectively).
IMI in patients with Paget’s disease of the tibia
In patients with Paget’s disease a mean of 11 indentations
(range, 10 to 12) were performed in the affected tibias and 12
indentations (range, 10 to 16) were performed in the non-
Pagetic tibia in order to obtain 10 adequate measurements of
each tibia. Mean BMSi of Pagetic bone was lower, albeit
nonsignificantly, than that of the contralateral nonaffected bone
(74.7 1.7 and 78.7 1.3, respectively; p¼ 0.120). In contrast to
the observations in subjects without Paget’s disease, the
variability of measured BMSu values of the Pagetic tibia was
greater than that of the contralateral tibia (Figs. 4A,B and 5).
This was confirmed by the significant difference in mean SDs of
BMSu measurements between Pagetic and non-Pagetic bones
(7.6 versus 5.0, respectively, p¼ 0.008). In none of the patients
with Paget’s disease was the SD of BMSu larger in the unaffected
bone compared to the affected one.
Discussion
The in vivo measurement of IMI in the tibia of humans using the
OsteoProbe is a new technique that provides information about
tissue-level material properties of cortical bone. Although the
relationship between measured properties of bone and its
traditional mechanical properties still needs to be determined,
clinical studies have demonstrated that the method could
differentiate patient groups at increased risk for fracture from
control groups independently of BMD values, suggesting that
the method measures aspects of bone fragility not captured by
BMD.(7,11–13) In the present study we report for the first time
serial indentations of both legs in all tested subjects to address
issues related to the proper application of this technique in
clinical practice and to directly examine properties of cortical
bone in patients with Paget’s disease of the tibia compared to
cortical bone of nonpathologic tibias.
Results obtained by in vivo, non-automated methods of
investigation are subject to variations that depend on the
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operator, on the performance of the procedure and on
underlying individual biological variance. Results obtained
using the OsteoProbe may be affected by all these factors
and adequate evaluation of these factors may help in explaining
somediscrepancies in reported results between different groups
that raised questions regarding the value of this method in the
clinic.(2)
The IMI method used in the present study does not
automatically exclude inadequate measurements, a task which
is left to the judgment of the operator. This has been an issue of
critique, particularly because there has been no specific
reference to flagged results in most reported studies so far.
Our data from this study show that in the hands of an
experienced operator, who applied exclusion of inadequate
indentations without knowledge of the result, up to 16
indentations was needed in order to obtain 10 adequate
measurements. Although we have no data to compare the
performance of different operators, our previous results with a
single operator showing minimal intraobserver variation are
clearly at odds with studies reporting results obtained by
different operators, which showed large and significant
variations in measured BMSi values requiring statistical adjust-
ment of the results.(14) This confirms the notion that an
experienced operator is a sine qua non for the successful
clinical application of the technique. If this is not feasible,
additional operators should undergo a period of training with
continuous comparison of their performance with that of an
experienced operator. Relevant to this issue is the variable
number of indentations required for the final results in different
studies that ranged from five adequate to 15 in total.(7,11,14–16) In
the recent technical report of the application of OsteoProbe in
human studies, five adequate indentations are recommended to
be performed in each tested subject.(3) We found no difference
in final BMSi values between five and 10 adequate indentations,
a result that is in agreement with the recommendation.
However, more than five indentations may be required when
an intrinsic, operator-independent variability in values is
expected. The exclusion of the result of the first indentation
Fig. 2. Scatterplot of 10 sequential adequate indentations of both legs in two subjects (A, B) without tibia pathology.
Fig. 3. Scatterplot of standard deviations of mean BMSu of sequential adequate indentations. BMSu¼ unnormalized bone material strength.
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routinely and independently of the operator’s evaluation, as
used by some investigators, has also been recommended.(3) In
our study flagged measurements were evenly distributed
among sequential indentations for up to 16 indentations with
the exception of the first indentation that had to be flagged by
the operator in 10 of the 22 measurements in subjects without
Paget’s disease. This high number of inadequate first inden-
tations justifies the recommendation of routinely excluding the
first indentation value from the measurements. On the other
hand, a remarkable consistency of sequential results and
minimal variability in mean values was observed indicating a
robustmethod. Although variability may be greater in individual
subjects this did not seem to affect the final outcome. These
findings, together with the overlap of values between tested
control and patient groups in reported studies, suggest that
whereas the method can currently provide valid information in
groups of individuals, it cannot be recommended as yet for
drawing firm conclusions about tissue material properties of
cortical bone in individual patients. Finally, we show here that in
the absence of tibia pathology, there is no difference in
measured BMSi between the two legs. Although the harmonized
use of the nondominant leg is recommended for consistency of
data acquisition and for comparison of outcomes obtained with
the use of the OsteoProbe between different centers,(3) our
bilaterally obtained data do suggest that the investigator’s
choice of themost suitable leg for testingmay be allowed as this
does not compromise the outcome of the procedure.
Taken at face value, our first ever reported results of IMI in
patients with Paget’s disease of the tibia unexpectedly showing
no significant decrease in BMSi in the affected compared to the
normal tibia may seem surprising and perhaps disappointing
about the value of IMI in discerning abnormal tissue level
properties of cortical bone in Pagetic tibias.(17) However, a
caveat in the interpretation of these results as well as of the
absence of complications of the procedure in pathological tibias,
may be because of the small number of patients studied, limiting
the power of the study to detect significant differences between
healthy and pathological bone or to capture complications. It is
also of note that all nine patients with Paget’s disease were in
biochemical remission for longer than 1 year following
treatment with bisphosphonates and none had sustained a
stress or complete fracture of the tibia or had been subjected to
a corrective surgical procedure. Whereas the finding of no
significant BMSi difference between pathological and healthy
tibias in patients with Paget’s disease in our studymay well have
been related to bisphosphonate treatment and long-term
remission of the disease, our data cannot address this
assumption, because we did not investigate treatment-naive
patients. Interestingly, Mellibovsky and colleagues(15) recently
reported that risedronate treatment given for 20 weeks to
patients treated with glucocorticoids significantly improved
BMSi before any measurable change in BMD could be observed.
The most important novel finding in our study was the wide
variability of adequate measurements of BMSu of the affected
Pagetic tibia indicating a heterogeneity of tissue properties
Fig. 4. Scatterplot of 10 sequential adequate indentations of the healthy and of the affected tibia in 2 patients (A, B) with Paget’s disease of bone.
Fig. 5. Box-plots of BMSu values of healthy and affected tibias of all
patients with Paget’s disease of bone included in the study. BMSu¼
unnormalized bone material strength.
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associated with the bone pathology of the disease. In this
disorder, the localized accelerated bone remodeling results in
the deposition of a disorganized mosaic of woven and lamellar
bone leading to heterogeneous structural changes at affected
skeletal sites. The BMSu values we recorded were very variable:
within or higher than the range of values of the contralateral
non-Pagetic tibia, interspersed with very low measured values.
The variability of these measurements reveals a new, previously
unreported, heterogeneous pattern of tissue level properties of
pathological bone that is not due to methodological inadequa-
cies and cannot be readily explained. This finding raises, in
addition, the question whether variability of adequately
performed indentations in individual subjects may enable the
identification of aspects of biological variance of bone
properties that are not captured by mean BMSi values. This
issue warrants further investigation in appropriately selected
patients or groups of patients.
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